
This work was supported in part by grants from Instituto de Salud Carlos III (PI15/00238) to Anna Santamaria. This work was funded by the Instituto de Salud Carlos III through the projects (PI23/01144), (ICI21000/76), (FORT23/00034) (Co-funded by the European Regional Development Fund/European Social Fund; “A way to make Europe”/“Investing in your future”) to Miguel F. Segura. Marta Barber was supported by predoctoral fellowship from AGAUR (2020 FI_B 00058). This work was funded by Ministerio de Ciencia e Innovación (#PID2022-137332OB-I00) and ajuts d'Indústria del Coneixement (2021 PROD 00059) to Nora Ventosa.
Transición epitelial-mesenquimal; Metástasis; Cáncer de ovario
Epithelial-mesenchymal transition; Metastasis; Ovarian cancer
Transició epitelial-mesenquimal; Metàstasi; Càncer d'ovari
Medicine (General), Other subheadings::Other subheadings::Other subheadings::/drug therapy, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Ovaris - Càncer - Aspectes genètics, Ovaris - Càncer - Tractament, Cèl·lules - Motilitat, FENÓMENOS Y PROCESOS::fenómenos fisiológicos celulares::movimiento celular, PHENOMENA AND PROCESSES::Cell Physiological Phenomena::Cell Movement, PHENOMENA AND PROCESSES::Cell Physiological Phenomena::Cell Transdifferentiation::Epithelial-Mesenchymal Transition, Letter to the Journal, Proteïnes quinases, R5-920, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias ováricas, FENÓMENOS Y PROCESOS::fenómenos fisiológicos celulares::transdiferenciación celular::transición epiteliomesenquimatosa, CHEMICALS AND DRUGS::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Serine-Threonine Kinases, DISEASES::Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Ovarian Neoplasms, COMPUESTOS QUÍMICOS Y DROGAS::enzimas y coenzimas::enzimas::transferasas::fosfotransferasas::fosfotransferasas (grupo alcohol aceptor)::proteína cinasas::proteína-serina-treonina cinasas
Medicine (General), Other subheadings::Other subheadings::Other subheadings::/drug therapy, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Ovaris - Càncer - Aspectes genètics, Ovaris - Càncer - Tractament, Cèl·lules - Motilitat, FENÓMENOS Y PROCESOS::fenómenos fisiológicos celulares::movimiento celular, PHENOMENA AND PROCESSES::Cell Physiological Phenomena::Cell Movement, PHENOMENA AND PROCESSES::Cell Physiological Phenomena::Cell Transdifferentiation::Epithelial-Mesenchymal Transition, Letter to the Journal, Proteïnes quinases, R5-920, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias ováricas, FENÓMENOS Y PROCESOS::fenómenos fisiológicos celulares::transdiferenciación celular::transición epiteliomesenquimatosa, CHEMICALS AND DRUGS::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Serine-Threonine Kinases, DISEASES::Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Ovarian Neoplasms, COMPUESTOS QUÍMICOS Y DROGAS::enzimas y coenzimas::enzimas::transferasas::fosfotransferasas::fosfotransferasas (grupo alcohol aceptor)::proteína cinasas::proteína-serina-treonina cinasas
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
